MiniMed Group, Inc. (MMED)
About MiniMed Group, Inc.
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2026
- $2.3B
- Net income
- -$148.0M
- Total assets
- $4.3B
- Market cap
- $4.7B
- Gross margin
- 54.2%
- Operating margin
- -6.1%
- Net margin
- -10.2%
Source: SEC EDGAR · updated Jun 7, 2026
Financial statements
Income statement
- Revenue
- $3.1B
- Cost of revenue
- $1.4B
- Gross profit
- $1.7B
- Operating expenses
- $1.9B
- Operating income
- -$190.0M
- Income tax
- $128.0M
- Net income
- -$317.0M
- EPS (basic)
- $-1.30
- EPS (diluted)
- $-1.30
Balance sheet
- Total assets
- $4.6B
- Current assets
- $1.3B
- Total liabilities
- $1.0B
- Current liabilities
- $702.0M
- Shareholders’ equity
- $3.6B
Cash flow
- Operating cash flow
- -$197.0M
- Investing cash flow
- -$233.0M
- Financing cash flow
- $716.0M
- Net cash flow
- $286.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $4.7B
- EPS (diluted)
- $-1.3
- Shares outstanding
- 242.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Mar 6, 2026
MiniMed Group, Inc. (MMED) Stock Price
- Reported a net loss of $148.0M in FY2026.
- Gross margin of 54.2%, net margin -10.2%.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review MiniMed Group, Inc..
Write a review
News about MiniMed Group, Inc.
News & sentiment via Polygon.io
MiniMed Group, Inc.: frequently asked questions
Is MiniMed Group, Inc. an American company?
MiniMed Group, Inc. is a US-based company headquartered in Northridge, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is MiniMed Group, Inc. headquartered?
MiniMed Group, Inc. is headquartered in Northridge, California, United States.
Is MiniMed Group, Inc. publicly traded?
Yes — MiniMed Group, Inc. is a publicly traded company. Its stock trades under the ticker symbol MMED on the NASDAQ.
What does MiniMed Group, Inc. do?
MiniMed Group, Inc. is an American Medical Devices company in the Health & Beauty sector.
